Notably, one individual in the vaccinated cohort and two in the dengue-recovered cohort showed no detectable cross-reactive anti-E IgG antibodies, while one individual in the dengue-recovered cohort lacked cross-reactivity for IgA (Figures 3C2, C3). Here, CD79A is linked to dengue disease.